EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cysteine‐Rich Protein 61 (CCN1) Deficiency Alleviated Cardiac Remodeling in 5/6 Nephrectomized Mice by Suppressing the MAPK Signaling Pathway

Yihan Zhao, Liang Gu, Yunxuan Chen, Yibei Lin, Jincheng Xing, Diyan Xu, Zhen Su iD, Zhouqing Huang iD

Cardiovascular Therapeutics · 2025

DOI: 10.1155/cdr/6813183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Yihan Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Cardiovascular Disease of Wenzhou, Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzh…. Hauptthemen laut MEDLINE: Nephrectomy, Cysteine-Rich Protein 61, Ventricular Remodeling, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, Wenzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With the progression of chronic kidney disease (CKD), we can often observe cardiac remodeling, fibrosis, and cardiac failure in patients. Cysteine‐rich protein 61 (CCN1) is an extracellular matrix protein that plays a reuse role in cardiac remodeling. However, whether CCN1 participates in the crosslink between the heart and kidney in CKD and the potential mechanism remains unknown.

Methods

We constructed a mouse model of CKD by 5/6 nephrectomy (5/6 Nx). Hematoxylin–eosin staining (H&E), Masson’s trichrome staining, and Sirius red staining were used to observe cardiac morphology and fibrosis. H9c2 cells were treated with si‐CCN1 or si‐NC or mitogen‐activated protein kinase (MAPK)–related inhibitors or agonist before being cultured with 5/6 Nx mouse serum. The relative protein level was detected by Western blotting.

Results

We observed that CCN1 expression was markedly enhanced in the serum and heart tissues, accompanied by disordered myocardial arrangement, obvious cardiac fibrosis, hypertrophy, and decreased cardiac systolic function reflected by echocardiography. The relative markers collagen 1 (COL‐1), transforming growth factor‐ β (TGF‐ β ), heavy‐chain cardiac myosin (MyHC), and atrial natriuretic peptide (ANP) presented an increase in expression. In vivo and in vitro, after the knockdown of CCN1, the above results in the CKD group or CKD serum group were reversed; in addition, the MAPK signaling pathway was obviously activated due to 5/6 Nx, which was abolished by CCN1 inhibition. CCN1 silencing or MAPK pathway inhibition also decreased the expression of myocardial fibrosis and hypertrophy markers in H9c2 cells, while MAPK‐related agonist partly reversed the effect of CCN1 inhibition.

Conclusion

Our in vivo and in vitro study showed that specific CCN1 deficiency markedly alleviated cardiac remodeling in 5/6 Nx mice through the inhibition of the MAPK pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrectomyCysteine-Rich Protein 61Ventricular RemodelingRenal Insufficiency, ChronicMyocytes, CardiacVentricular Function, LeftMAP Kinase Signaling SystemHypertrophy, Left VentricularMitogen-Activated Protein Kinase KinasesAnimalsDisease Models, AnimalFibrosisMaleMice, Inbred C57BLCell LineRatsMice

Stichwörter der Autor:innen

5/6 nephrectomy miceCCN1MAPK signaling pathwaycardiac remodeling

Substanzen

Cysteine-Rich Protein 61CCN1 protein, mouseMitogen-Activated Protein Kinase Kinases

Autor:innen und Institutionen

  • The Key Laboratory of Cardiovascular Disease of Wenzhou, Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Cardiology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
  • Department of Nephrology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of General Medicine, Mianyang Central Hospital, Mianyang, Sichuan, China.

ORCID-Profile: Zhen Su, Zhouqing Huang

Förderung

  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Wenzhou Municipal Science and Technology Bureau
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zhao, Y., Gu, L., Chen, Y., Lin, Y., Xing, J., Xu, D., Su, Z., & Huang, Z. (2025). Cysteine‐Rich Protein 61 (CCN1) Deficiency Alleviated Cardiac Remodeling in 5/6 Nephrectomized Mice by Suppressing the MAPK Signaling Pathway. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/6813183

Vancouver

Zhao Y, Gu L, Chen Y, Lin Y, Xing J, Xu D, et al. Cysteine‐Rich Protein 61 (CCN1) Deficiency Alleviated Cardiac Remodeling in 5/6 Nephrectomized Mice by Suppressing the MAPK Signaling Pathway. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/6813183

BibTeX
@article{Zhao2025,
  author = {Zhao, Yihan and Gu, Liang and Chen, Yunxuan and Lin, Yibei and Xing, Jincheng and Xu, Diyan and Su, Zhen and Huang, Zhouqing},
  title = {Cysteine‐Rich Protein 61 (CCN1) Deficiency Alleviated Cardiac Remodeling in 5/6 Nephrectomized Mice by Suppressing the MAPK Signaling Pathway},
  journal = {Cardiovascular Therapeutics},
  year = {2025},
  doi = {10.1155/cdr/6813183}
}
Kostenlos starten →